These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7427657)

  • 21. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is aminoglutethimide an alternative to adrenalectomy for metastatic carcinoma of the breast?
    Sterns EE; Bird CE; Mackie KW
    Can J Surg; 1982 Nov; 25(6):695-7. PubMed ID: 7139430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminoglutethimide-induced leukopenia: a case report and review of the literature.
    Gez E; Sulkes A
    Oncology; 1984; 41(6):399-402. PubMed ID: 6504495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aminoglutethimide in metastasizing carcinoma of the breast resistant to hormonal and cytostatic treatment (author's transl)].
    Rieche K
    Dtsch Med Wochenschr; 1981 Oct; 106(40):1296-300. PubMed ID: 7274074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment.
    Halpern J; Catane R; Baerwald H
    J Med; 1984; 15(1):59-63. PubMed ID: 6149250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of hormone therapy with aminoglutethimide (Rodazol) in postmenopausal metastatic breast cancer].
    Schmidt UM; Brockmann B; Geschke E
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):276-9. PubMed ID: 1713564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe thrombocytopenia following the administration of aminoglutethimide.
    Katz ME
    Conn Med; 1984 Jul; 48(7):423-4. PubMed ID: 6467929
    [No Abstract]   [Full Text] [Related]  

  • 29. [Aminoglutethimide in the treatment of metastatic breast carcinoma].
    Vasović S; Nesković-Konstantinović Z; Susnjar S; Stamatović Lj; Nesković B; Mitrović L; Jelić S
    Srp Arh Celok Lek; 1999; 127(9-10):333-7. PubMed ID: 10649904
    [No Abstract]   [Full Text] [Related]  

  • 30. Aminoglutethimide in the treatment of metastatic breast cancer.
    Troner MB
    Cancer Res; 1982 Aug; 42(8 Suppl):3402s-3404s. PubMed ID: 7083206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer drug adrenalectomy 'passes'.
    Henahan J
    JAMA; 1984 Jan; 251(3):310. PubMed ID: 6690789
    [No Abstract]   [Full Text] [Related]  

  • 33. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.
    Höffken K; Kempf H; Miller AA; Miller B; Schmidt CG; Faber P; Kley HK
    Cancer Treat Rep; 1986 Oct; 70(10):1153-7. PubMed ID: 3756937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experiences with Rodazol therapy in the treatment of postmenopausal patients with metastatic breast cancer].
    Stier G; Gürtler R; Schmidt UM; Müller U; Tanneberger S
    Zentralbl Gynakol; 1990; 112(17):1101-4. PubMed ID: 2264420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoglutethimide vs. surgical adrenalectomy in breast cancer.
    N Engl J Med; 1982 Jan; 306(1):44-6. PubMed ID: 7053472
    [No Abstract]   [Full Text] [Related]  

  • 36. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
    J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
    Young JA; Newcomer LN; Keller AM
    Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
    Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
    [No Abstract]   [Full Text] [Related]  

  • 39. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
    Smith IE; Harris AL; Morgan M; Ford HT; Gazet JC; Harmer CL; White H; Parsons CA; Villardo A; Walsh G; McKinna JA
    Br Med J (Clin Res Ed); 1981 Nov; 283(6304):1432-4. PubMed ID: 6797571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of aminoglutethimide as second-line endocrine therapy in metastatic breast cancer.
    Kaye SB; Woods RL; Fox RM; Coates AS; Tattersall MH
    Cancer Res; 1982 Aug; 42(8 Suppl):3445s-3447s. PubMed ID: 6177404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.